Conexeu Sciences Inc.
corporate_fare Company Profile
Conexeu Sciences Inc. (NASDAQ:CNXU) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 8 items for CNXU at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-14, rated 8/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for CNXU spans 10-Q, 8-K, 424B3.
Recent high-impact activity:
- Conexeu Sciences Q3 Loss Widens to $7.7M; Cash Runway Shrinks, Going Concern Warning Reiterated
- Conexeu Sciences Discloses $1.9M in Unregistered Share Issuances Amid Going-Concern Warning
- Conexeu Completes Preclinical Study for Large-Volume Injectable, Eyes $2B Aesthetics Market
- Conexeu Completes Key Preclinical Study for CXU™ Platform, Targets Q1 2027 FDA Submission
- Conexeu Sciences Opens New Vancouver R&D Hub to Boost Regenerative Tissue Platform
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 172,079 shares in CNXU as of the September 15, 2026 settlement, a 15.0% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 37.4% of CNXU volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for CNXU, detected from its recent SEC filings · based on capital-structure filings through 2026-09-14.
Highly Dilutive Offering · Going Concern Warning
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →